Table 2.
IGF-1 levels and type of therapy by number of included medicines in the therapeutic scheme.
| Type of Therapy/IGF-1 Levels in nmol/L | No Treatment (n1 = 12; n2 = 39) |
Monotherapy (n1 = 48; n2 = 96) |
Combination Therapy (n1 = 22; n2 = 34) |
p Value |
|---|---|---|---|---|
| IGF-1 levels at the previous hospitalization | 27 (95% CI 18.142–32.044) |
18.8 (95% CI 15.244–24.035) |
21.5 (95% CI 18.53–38.66) |
0.4567 * |
| IGF-1 levels at the current hospitalization | 23.6 (95% CI 18.96–34.508) |
23.8 (95% CI 20.492–28.155) |
26.65 (95% CI 19.856–28.939) |
0.9591 * |
* not statistically significant. n1—number of patients at the previous hospitalization; n2—number of patients at the current hospitalization in 2021.